首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Transferable Plasmid-Mediated Resistance to Linezolid Due to cfr in a Human Clinical Isolate of Enterococcus faecalis
【2h】

Transferable Plasmid-Mediated Resistance to Linezolid Due to cfr in a Human Clinical Isolate of Enterococcus faecalis

机译:在人类粪肠球菌临床分离株中由于cfr引起的可转移质粒介导的对利奈唑胺的抗药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nonmutational resistance to linezolid is due to the presence of cfr, which encodes a methyltransferase responsible for methylation of A2503 in the 23S rRNA. The cfr gene was first described in animal isolates of staphylococci, and more recently, it has been identified in Staphylococcus aureus from human clinical infections, including in an outbreak of methicillin-resistant S. aureus. In enterococci, cfr has been described in an animal isolate of Enterococcus faecalis from China. Here, we report an isolate of linezolid-resistant E. faecalis (603-50427X) recovered from a patient in Thailand who received prolonged therapy with the antibiotic for the treatment of atypical mycobacterial disease. The isolate lacked mutations in the genes coding for 23S rRNA and L3 and L4 ribosomal proteins and belonged to the multilocus sequence type (MLST) 16 (ST16), which is commonly found in enterococcal isolates from animal sources. Resistance to linezolid was associated with the presence of cfr on an ∼97-kb transferable plasmid. The cfr gene environment exhibited DNA sequences similar to those of other cfr-carrying plasmids previously identified in staphylococci (nucleotide identity, 99 to 100%). The cfr-carrying plasmid was transferable by conjugation to a laboratory strain of E. faecalis (OG1RF) but not to Enterococcus faecium or S. aureus. The cfr gene was flanked by IS256-like sequences both upstream and downstream. This is the first characterization of the potential horizontal transferability of the cfr gene from a human linezolid-resistant isolate of E. faecalis.
机译:对利奈唑胺的非突变抗性归因于cfr的存在,其编码23S rRNA中负责A2503甲基化的甲基转移酶。 cfr基因最初是在葡萄球菌的动物分离物中描述的,最近,它已在人类临床感染的金黄色葡萄球菌中鉴定出来,包括在耐甲氧西林的金黄色葡萄球菌的爆发中。在肠球菌中,cfr在中国粪肠球菌的动物分离物中已有描述。在这里,我们报告了从泰国患者中回收的耐利奈唑胺的粪肠球菌的分离株(603-50427X),该患者接受了长时间的抗生素治疗,以治疗非典型的分枝杆菌病。该分离株在编码23S rRNA和L3和L4核糖体蛋白的基因中缺乏突变,属于多基因座序列类型(MLST)16(ST16),通常在动物来源的肠球菌分离物中发现。对利奈唑胺的抗性与〜97kb可转移质粒上cfr的存在有关。 cfr基因环境显示的DNA序列与以前在葡萄球菌中鉴定出的其他cfr携带质粒的序列相似(核苷酸同一性为99%到100%)。携带cfr的质粒可通过偶联转移至粪肠球菌的实验室菌株(OG1RF),但不能转移至粪肠球菌或金黄色葡萄球菌。 cfr基因在上游和下游均侧接IS256样序列。这是 cfr 基因从 E的抗人耐利奈唑胺分离株的潜在水平水平可转移性的首次表征。粪便

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号